Waystar
Waystar is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Waystar.
Waystar is a company.
Key people at Waystar.
Key people at Waystar.
Waystar is a leading cloud-based healthcare revenue cycle management (RCM) software company that provides mission-critical tools to simplify payments for providers. It offers solutions for financial clearance, patient financial care, claims and payment management, denial prevention and recovery, revenue capture, and analytics, serving approximately 30,000 clients representing over 1 million distinct providers, including 16-18 of the top U.S. News Best Hospitals.[1][2][5][6] The platform processes over 5-6 billion transactions and $1.2-1.8 trillion in gross claims annually, spanning about 50% of U.S. patients, enabling providers to optimize revenue, reduce administrative burdens, and focus on patient care.[2][5][6]
Waystar demonstrates strong growth momentum, with revenue up 15% year-over-year to $270.7 million in Q2 2025, on track for $1 billion in 2025 (from $944 million in 2024), consistent quarterly growth for two years, 115% net revenue retention, and 15% year-over-year increase in scaled clients.[1][2] It maintains robust margins, a solid balance sheet ($4.7 billion assets vs. $1.5 billion liabilities as of Q2 2025), and innovations like AltitudeAI, which accelerates denial appeals 3x faster and boosts overturn rates by over 40%.[1][2]
Waystar was formed in November 2017 through the merger of two top-tier healthcare payment software companies, Navicure and ZirMed, backed by Bain Capital and led by CEO Matt Hawkins.[3][5] This combination created a unified platform in the fragmented RCM market, headquartered in Lehi, Utah (with operations also in Louisville, Ky., and Duluth, Minn.), growing from $60 million in revenue to over $600 million by 2022 via organic expansion and acquisitions.[1][3]
The idea emerged from Bain Capital's expertise in payments, software, and healthcare, using a transformational M&A approach to build scale.[3] Early traction came from rapid integration and growth, serving over 500,000 providers by processing nearly $1 trillion in claims annually.[3] Key pivots included sales to EQT Partners and CPPIB in 2019, an IPO, and S&P SmallCap 600 inclusion in September 2025, underscoring execution under Hawkins.[2][3][4]
Waystar stands out in the $5 billion RCM technology market through:
Waystar rides the wave of healthcare digitization and AI adoption in a $5 billion RCM market growing above GDP rates, driven by provider expansion, tech penetration, and shifts to value-based care amid rising costs and administrative complexity.[4][7] Timing is ideal post-IPO and amid payer-provider tensions, where outdated manual processes burden 50%+ of U.S. patients' claims; Waystar's cloud/AI unification captures share from legacy competitors.[2][4][6]
Market forces like AI automation, regulatory demands for transparency (e.g., price estimates), and consolidation favor Waystar's flexible platform and integration expertise.[3][4][5] It influences the ecosystem by partnering with EHR vendors, enabling 1M+ providers to prioritize care, and setting benchmarks via innovations that boost cash flow—positioning it as the long-term U.S. leader.[1][3][6]
Waystar's trajectory points to sustained leadership, targeting $1B+ revenue in 2025 with double-digit growth, debt reduction, and AI expansions like generative tools for deeper cross-sell and hospital wins.[1][2][4] Upcoming trends—AI/ML proliferation, RCM fragmentation (consolidation plays), and payer shifts—will amplify its edge, potentially driving P/E expansion beyond 25x amid 15%+ sales momentum.[1][4][7]
As the top cloud RCM player processing trillions in claims, Waystar will evolve influence by automating more of healthcare's $1T+ payment friction, delivering shareholder value through durable margins and scale—cementing its role as providers' "guiding star" for revenue clarity.[2][3][5]
